McMorgan & Co’s Cerence CRNC Stock Holding History

McMorgan & Co’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,953	Closed	-$1.45M	–	55
2021 Q4	$1.45M	Buy	18,953 +10,501	+124%	+$926K	0.26%	34
2021 Q3	$812K	Buy	+8,452	New	+$923K	0.16%	47

Other funds holding CRNC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

McMorgan & Co's CRNC Position: Q1 2022 in Review

McMorgan & Co sold out of Cerence (CRNC) in Q1 2022, closing a stake of 18,953 shares — an estimated $1.45M sold.

McMorgan & Co first reported a position in CRNC in Q3 2021 and held it in 2 quarters. The position peaked at $1.45M in Q4 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

McMorgan & Co reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
McMorgan & Co sold 18,953 Cerence shares in Q1 2022, an estimated $1.45M.
McMorgan & Co first reported a position in Cerence in Q3 2021 and held it in 2 quarters.
McMorgan & Co's Cerence position peaked at $1.45M in Q4 2021.
286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on McMorgan & Co's 13F filing for Q1 2022, filed 17 May 2022.